Why Co-Diagnostics Stock Rose 15.8% on Monday
The molecular testing company is expected to benefit from the rise in cases of the omicron COVID-19 variant.
Source: fool.com
Page 16 - Logix Smart News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Logix Smart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Logix Smart Today - Breaking & Trending Today
Co-Diagnostics to Acquire Idaho Molecular, Advanced Conceptions for up to $50M
Co-Diagnostics said it has been developing its upcoming sample-to-answer YourTest at-home/point-of-care diagnostic device with the two privately held companies.
Source: genomeweb.com
Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant
SALT LAKE CITY, Nov. 29, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
Source: hjnews.com
Co-Diagnostics Inc. says its suite of coronavirus diagnostics not affected by heavily mutated Omicron variant
“We are pleased to report that none of the over 50 mutations in this new variant are close enough to the targets of any of our COVID-19...
Source: proactiveinvestors.com